EX-23.1 3 rnaz-20211231xex23d1.htm EXHIBIT-23.1

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Registration No. 333-257868) of TransCode Therapeutics, Inc. of our report dated March 31, 2022, which includes an explanatory paragraph relating to the Company’s ability to continue as a going concern, relating to the financial statements of the Company as of and for the years ended December 31, 2021 and 2020, which appear in this Form 10-K.

/s/ Withum Smith+Brown, PC

East Brunswick, New Jersey

March 31, 2022